glp-1 eating disorders #504: Adult in the Era GLP-1 Medications and Eating Disorders:

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

Reduce hunger* Contains Supresa, a patented saffron extract shown to reduce snacking and decrease hunger, with 69% of participants reporting reduced hunger within 8 weeks

The association was consistent across alcohol- and non-alcohol-related overdoses and was even stronger among patients not receiving traditional addiction-treatment medications

Diverticular disease develops due to a lack of dietary fiber, and is most common in the elderly, but many people never realize they have it because there are few symptoms....

Andrew Huberman explores how peptides, AI, and emerging technologies are reshaping American health

Best results after 3 months of consistent, daily use